1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Interleukin-6: new trials by email Literature Review of Interleukin-6 trials Research Report on Interleukin-6
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment Tocilizumab, NaCl 0.9% 100ml - Interleukin-6, Ischemic Stroke | Phase 2 / Phase 3 | Completed | Suzhou Municipal Hospital of Anhui Province | 108 | 2024-02-02 | 2024-09-25 |
Ischemic Stroke (1)
Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Nervous System Diseases (1) · Stroke (1) · Vascular Diseases (1)
tocilizumab (1)
Suzhou Municipal Hospital of Anhui Province (1)
China (1)
Chuanjie Wu, M.D. (1) · Xuehong Chu, M.D. (1) · Xunming Ji, M.D. (1) · Zhengfei Ma, M.M. (1)